Regeneron

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years – Regeneron Pharmaceuticals (NASDAQ:REGN)

1 minute read

FFinance

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years – Regeneron Pharmaceuticals (NASDAQ:REGN)

bytady
June 4, 2025

Regeneron Pharmaceuticals REGN has outperformed the market over the past 15 years by 9.69% on an annualized basis…

Temu Parent PDD, Regeneron Pharmaceutical And Burlington Stores Are Among Top 11 Large-Cap Losers Last Week (May 26-May 30): Are The Others In Your Portfolio? – PDD Holdings (NASDAQ:PDD), Burlington Stores (NYSE:BURL), Regeneron Pharmaceuticals (NASDAQ:REGN)

2 minute read

FFinance

Temu Parent PDD, Regeneron Pharmaceutical And Burlington Stores Are Among Top 11 Large-Cap Losers Last Week (May 26-May 30): Are The Others In Your Portfolio? – PDD Holdings (NASDAQ:PDD), Burlington Stores (NYSE:BURL), Regeneron Pharmaceuticals (NASDAQ:REGN)

bytady
June 1, 2025

These eleven large-cap stocks were the worst performers in the last week. Are they in your portfolio? Summit…

1 minute read

FFinance

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years – Regeneron Pharmaceuticals (NASDAQ:REGN)

bytady
May 22, 2025

Regeneron Pharmaceuticals REGN has outperformed the market over the past 15 years by 10.66% on an annualized basis…

3 minute read

FFinance

Regeneron Buys 23andMe for $256M After Bankruptcy

bytady
May 20, 2025

Bankrupt 23andMe to Be Acquired by Regeneron for $256 Million. Genetic testing company 23andMe has announced it will…

Regeneron Pharmaceuticals To Buy 23andMe and Its Data For 6 Million

1 minute read

TTech

Regeneron Pharmaceuticals To Buy 23andMe and Its Data For $256 Million

bytady
May 19, 2025

Regeneron Pharmaceuticals is acquiring most of 23andMe’s assets for $256 million. The sale includes 23andMe’s Personal Genome Service,…

23andMe sold out of bankruptcy to Regeneron

2 minute read

FFinance

23andMe sold out of bankruptcy to Regeneron

bytady
May 19, 2025

Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to…

Regeneron is buying 23andMe out of bankruptcy for 6 million

1 minute read

FFinance

Regeneron is buying 23andMe out of bankruptcy for $256 million

bytady
May 19, 2025

Regeneron (REGN): Market Overlooks A Resilient Franchise And Robust Free Cash Flow

2 minute read

FFinance

Regeneron (REGN): Market Overlooks A Resilient Franchise And Robust Free Cash Flow

bytady
April 6, 2025

This article was written by Follow With a background as an RN and an MBA, I analyze healthcare…

1 minute read

FFinance

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years – Regeneron Pharmaceuticals (NASDAQ:REGN)

bytady
February 14, 2025

Regeneron Pharmaceuticals REGN has outperformed the market over the past 15 years by 12.37% on an annualized basis…

4 minute read

FFinance

PayPal, UBS, Regeneron, Jacobs Announce Major Stock Buybacks

bytady
February 6, 2025

These four large-cap stocks recently announced buyback programs that are moderate to massive in size when compared to…

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years – Regeneron Pharmaceuticals (NASDAQ:REGN)

Temu Parent PDD, Regeneron Pharmaceutical And Burlington Stores Are Among Top 11 Large-Cap Losers Last Week (May 26-May 30): Are The Others In Your Portfolio? – PDD Holdings (NASDAQ:PDD), Burlington Stores (NYSE:BURL), Regeneron Pharmaceuticals (NASDAQ:REGN)

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years – Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Buys 23andMe for $256M After Bankruptcy

Regeneron Pharmaceuticals To Buy 23andMe and Its Data For $256 Million

23andMe sold out of bankruptcy to Regeneron

Regeneron is buying 23andMe out of bankruptcy for $256 million

Regeneron (REGN): Market Overlooks A Resilient Franchise And Robust Free Cash Flow

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years – Regeneron Pharmaceuticals (NASDAQ:REGN)

PayPal, UBS, Regeneron, Jacobs Announce Major Stock Buybacks

Apple to give app developers access to its artificial intelligence models

Skipped Brett ICO? This Stealthy Presale Is Purring Toward a 319.8% Crypto Boom You Need to Catch

Apple makes major AI advance with image generation technology rivaling DALL-E and Midjourney

Community Divided Over Developers’ New Policy

Salary, Cars & Real Estate

Every WWDC should end with a song composed of app reviews

Stablecoin Firm Plasma Secures $500 Million from Initial Coin Offering on Sonar